Beginning today, approximately one million individuals in England are eligible to receive a free meningitis B vaccine through the NHS. This initiative is a direct response to a series of recent deadly outbreaks of the disease.
The vaccine is available to all 17 and 18-year-olds currently in their final year of sixth form, as well as all students under the age of 25 who are commencing their first year at residential colleges or universities this autumn. The program provides a one-off vaccination opportunity designed to ensure students are protected before the typical rise in meningitis cases during the fall.
Meningococcal B (MenB) infection can lead to severe and life-threatening conditions, including inflammation of the brain's lining and sepsis, also known as blood poisoning. The consequences can be devastating, resulting in permanent disabilities such as amputations, hearing loss, and brain damage, and in some instances, can be fatal.
The bacteria responsible for MenB are spread through close personal contact, including kissing, sharing drinks or vapes, and living in shared accommodation like university halls. Data from the UK's infant vaccination program indicates that vaccination has achieved approximately a 75% reduction in meningitis cases among vaccinated age groups.
Caroline Temmink, NHS director of vaccination, emphasized the increased risk for students due to close proximity in new living and social environments. "Heading off to university is an exciting time, but it's also when the risk of MenB disease is higher as you spend lots of time with new people in shared living spaces, making it easier for the bacteria that cause this potentially deadly disease to spread," she stated. She urged eligible individuals to book their jab before departing for university.
The vaccination program was announced by the government last month, following outbreaks that tragically claimed the lives of two teenagers in Kent. Research indicates that first-year university students face a risk of contracting MenB that is approximately seven times higher than that of their peers not attending university.
Eligible 17 and 18-year-olds can book appointments through the NHS National Booking Service for community pharmacies. Other eligible individuals can contact a participating pharmacy directly to schedule an appointment, with bookings starting on July 20.
Dr. Shamez Ladhani, a consultant epidemiologist at the UK Health Security Agency, highlighted the heightened risk for young adults entering university settings. "The risk of MenB rises sharply for young people starting university, where mixing closely with so many new people increases exposure to the bacteria," Dr. Ladhani explained. He added that completing both doses over the summer would offer substantial protection against most meningococcal strains.
While NHS England has not yet disclosed the total cost of the vaccination rollout, estimates suggest that if all one million eligible individuals receive the vaccine, the total cost could reach £220 million, based on the private cost of £220 for a full course of both injections.
This rollout coincides with the launch of a new School-Aged Vaccination Taskforce by the Department of Health and Social Care and the Department for Education, aimed at improving vaccine uptake. The Joint Committee on Vaccination and Immunisation is also reviewing the need for a broader, long-term vaccination program for young people. Health Secretary James Murray stated, "Vaccines save lives, which is why we're offering the Meningitis B vaccine to around one million students as part of vital actions we're taking to better protect young people."